Home » 26 billion in 2021

26 billion in 2021

Pfizer coronavirus vaccine revenue is projected to hit $26 billion in 2021 with production surge

A man receives a second dose of the Pfizer-BioNTech coronavirus vaccine at the Belgrade Fair in Belgrade, Serbia, on April 13. (Marko Djurica/Reuters) Drug giant says it made $3.5 billion in global sales of its coronavirus shot in the first quarter of 2021 and expects sales to rise throughout the year By Christopher Rowland Business of Health Care Reporter ( https://www.washingtonpost.com/business/2021/05/04/pfizer-covid-vaccine-revenue/) Pfizer on Tuesday said it expects global sales of its coronavirus vaccine to reach $26 billion in 2021, a milestone that would make it the biggest-selling pharmaceutical product in the world and helps illustrate why Pfizer is planning to expand use of mRNA technology for other vaccines and therapies. Sales of its mRNA vaccine are likely to eclipse Humira,...